Bystanders or not? Microglia and lymphocytes in aging and strokeJustin N.Nguyen, Anjali Chauhan1397-1403
Alzheimer's disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegenerationEugenia Olivera, Albany Sáez, Lila Carniglia, Carla Caruso, Mercedes Lasaga, Daniela Durand1404-1410
Serine and arginine rich splicing factor 1: a potential target for neuroprotection and other diseasesAna M.Sandoval-Castellanos, Anushka Bhargava, Min Zhao, Jun Xu, Ke Ning1411-1416
Can glial cells save neurons in epilepsy?Weida Shen, Jelena Bogdanovi? Pristov, Paola Nobili, Ljiljana Nikoli?1417-1422
Lights for epilepsy: can photobiomodulation reduce seizures and offer neuroprotection?Napoleon Torres-Martinez, Stephan Chabardes, John Mitrofanis1423-1426
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosisIlaria Martinelli, Elisabetta Zucchi, Cecilia Simonini, Giulia Gianferrari, Giovanna Zamboni, Marcello Pinti, Jessica Mandrioli1427-1433
CMT1A current gene therapy approaches and promising biomarkersMarina Stavrou, Kleopas A.Kleopa1434-1440
Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surfaceDan-Dan Liu, Chao-Yang Zhang, Jing-Ting Zhang, Li-Min Gu, Guo-Tong Xu, Jing-Fa Zhang1441-1449
Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson's diseaseTamara Andrea Alarcón, Sarah Martins Presti-Silva, Ana Paula Toniato Sim?es, Fabiola Mara Ribeiro, Rita Gomes Wanderley Pires1450-1456
Regulation of enolase activation to promote neural protection and regeneration in spinal cord injuryHannah M.McCoy, Rachel Polcyn, Naren L.Banik, Azizul Haque1457-1462
